Mechanical circulatory support for cardiac amyloidosis.

Michelle M KittlesonRobert M ColeJignesh PatelDanny RamzyElizabeth PassanoDavid H ChangDael R GeftLawrence CzerRobert VescioJoshua ChungJon A KobashigawaFrancisco ArabiaFardad EsmailianJaime D Moriguchi

Published in: Clinical transplantation (2019)

Over a 9-year period, patients with amyloid cardiomyopathy who required MCS at our institution all received durable biventricular MCS. For carefully selected patients, this approach is feasible with acceptable outcomes as bridge to transplantation.

Keyphrases

end stage renal disease
newly diagnosed
prognostic factors
left ventricular
patient reported outcomes
metabolic syndrome
mesenchymal stem cells
multiple myeloma
cell therapy
adipose tissue